astrazeneca plc
- U.S. must halt corporate inversions immediately or lose billions of tax dollars — and an important opportunity to reform the tax code
- Pfizer said on Monday it had abandoned its current attempt to buy AstraZeneca for nearly $118 billion — a deal watched warily by Maryland officials — as a deadline approached without a last-minute change of heart by the British drugmaker.
- Research labs closed by pharmaceutical giant Pfizer dot the country. Maryland officials don't want the state to join that list, so Pfizer's proposal to buy AstraZeneca — which employs 3,100 in the state — has prompted local angst.
- Gov. Martin O'Malley and Delaware's governor sent a joint letter to Pfizer Thursday expressing concerns about its plans to acquire pharmaceutical firm AstraZeneca, which employs thousands in both states.
- Biotechnology company MedImmune said Tuesday it has expanded a bioresearch collaboration it started with the University of System of Maryland.
-
- Saint Agnes gets grant to help African-American woman with heart disease.
- A Rockville company will study the feasibility of a new cancer medicine with the large pharmaceutical company AstraZeneca.
- MedImmune leaders say the company is at a key point in developing drugs for AstraZeneca and has grown despite fears its acquisition would hurt Maryland.
- Human Genome, which uses the human DNA sequence to develop targeted drugs, was able to raise its price to $14.25 for sale to London-based GlaxoSmithKline Plc, valuing the company at $3.6 billion. In April, GlaxoSmithKline offered to buy Human Genome for $13 a share, or $2.6 billion.
- A proposal to speed the approval of new prescription drugs has patient advocates and biotechnology firms, including many that are based in Maryland, hoping that Congress can deliver a rare dose of bipartisanship this year.
- Human Genome ultimately rebuffed a $2.6 billion offer by biopharmaceutical giant GlaxoSmithKline Plc, saying it was too low – though it has put itself on the market. Catalyst agreed to be acquired by a larger Illinois competitor for $4.4 billion.
- A Maryland plan to sell tax credits to insurance companies succeeded in raising $84 million in a novel online auction, and the revenue will be pumped into promising technology companies across the state over the next 18 months, officials said.